Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127736611 | 12773661 | 1 | I | 20140905 | 20160913 | 20160923 | 20160923 | EXP | GB-BAXTER-2016BAX047627 | BAXTER | 55.00 | YR | M | Y | 0.00000 | 20160923 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127736611 | 12773661 | 1 | PS | SODIUM CHLORIDE 0.9% INTRAVENOUS INFUSION BP | SODIUM CHLORIDE | 1 | Parenteral | D | U | 16677 | SOLUTION FOR INFUSION | ||||||||
| 127736611 | 12773661 | 2 | SS | SODIUM CHLORIDE 0.9% INTRAVENOUS INFUSION BP | SODIUM CHLORIDE | 1 | D | U | 16677 | ||||||||||
| 127736611 | 12773661 | 3 | SS | CHIROCAINE | LEVOBUPIVACAINE HYDROCHLORIDE | 1 | Parenteral | D | U | 0 | 13 | ML | |||||||
| 127736611 | 12773661 | 4 | SS | FENTANYL. | FENTANYL | 1 | Parenteral | D | U | 0 | 100 | UG | |||||||
| 127736611 | 12773661 | 5 | SS | LIDOCAINE. | LIDOCAINE | 1 | Parenteral | D | U | 0 | 30 | MG | |||||||
| 127736611 | 12773661 | 6 | SS | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | Parenteral | D | U | 0 | 5 | MG | |||||||
| 127736611 | 12773661 | 7 | SS | triamcinolone | TRIAMCINOLONE | 1 | Parenteral | D | U | 0 | 86 | MG | |||||||
| 127736611 | 12773661 | 8 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Unknown | 0 | 2 | MG | BID | ||||||||
| 127736611 | 12773661 | 9 | C | EPILIM | VALPROATE SODIUM | 1 | Unknown | 0 | 100 | MG | QD | ||||||||
| 127736611 | 12773661 | 10 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 0 | 400 | MG | |||||||||
| 127736611 | 12773661 | 11 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | PLUS EXTRA DOSE AT NIGHT | 0 | 400 | MG | ||||||||
| 127736611 | 12773661 | 12 | C | glucosamine sulphate | GLUCOSAMINE | 1 | Unknown | 0 | 2 | DF | TABLET | QD | |||||||
| 127736611 | 12773661 | 13 | C | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | Unknown | 10MG/5ML | 0 | ORAL SOLUTION | |||||||||
| 127736611 | 12773661 | 14 | C | RANITIDINE. | RANITIDINE | 1 | Unknown | 1-2 ONCE DAILY | 0 | QD | |||||||||
| 127736611 | 12773661 | 15 | C | TRAMADOL. | TRAMADOL | 1 | Unknown | ONE OR TWO 4 TIMES DAILY. | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127736611 | 12773661 | 1 | Sedation |
| 127736611 | 12773661 | 2 | Off label use |
| 127736611 | 12773661 | 3 | Sedation |
| 127736611 | 12773661 | 4 | Sedation |
| 127736611 | 12773661 | 5 | Sedation |
| 127736611 | 12773661 | 6 | Sedation |
| 127736611 | 12773661 | 7 | Sedation |
| 127736611 | 12773661 | 8 | Product used for unknown indication |
| 127736611 | 12773661 | 9 | Product used for unknown indication |
| 127736611 | 12773661 | 10 | Product used for unknown indication |
| 127736611 | 12773661 | 12 | Product used for unknown indication |
| 127736611 | 12773661 | 13 | Breakthrough pain |
| 127736611 | 12773661 | 14 | Product used for unknown indication |
| 127736611 | 12773661 | 15 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127736611 | 12773661 | DS |
| 127736611 | 12773661 | HO |
| 127736611 | 12773661 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127736611 | 12773661 | Ageusia | |
| 127736611 | 12773661 | Decreased appetite | |
| 127736611 | 12773661 | Depressed level of consciousness | |
| 127736611 | 12773661 | Dissociative amnesia | |
| 127736611 | 12773661 | Dysgeusia | |
| 127736611 | 12773661 | Dysgraphia | |
| 127736611 | 12773661 | Erythema | |
| 127736611 | 12773661 | Eye pain | |
| 127736611 | 12773661 | Facial paralysis | |
| 127736611 | 12773661 | Hallucination | |
| 127736611 | 12773661 | Headache | |
| 127736611 | 12773661 | Hemiparesis | |
| 127736611 | 12773661 | Hypoaesthesia oral | |
| 127736611 | 12773661 | Loss of consciousness | |
| 127736611 | 12773661 | Metamorphopsia | |
| 127736611 | 12773661 | Muscle spasms | |
| 127736611 | 12773661 | Muscle twitching | |
| 127736611 | 12773661 | Musculoskeletal stiffness | |
| 127736611 | 12773661 | Mydriasis | |
| 127736611 | 12773661 | Nausea | |
| 127736611 | 12773661 | Neck pain | |
| 127736611 | 12773661 | Nightmare | |
| 127736611 | 12773661 | Ocular hyperaemia | |
| 127736611 | 12773661 | Photophobia | |
| 127736611 | 12773661 | Rash erythematous | |
| 127736611 | 12773661 | Retrograde amnesia | |
| 127736611 | 12773661 | Skin warm | |
| 127736611 | 12773661 | Speech disorder | |
| 127736611 | 12773661 | Unresponsive to stimuli |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127736611 | 12773661 | 1 | 20140904 | 20140904 | 0 | |
| 127736611 | 12773661 | 3 | 20140904 | 20140904 | 0 | |
| 127736611 | 12773661 | 4 | 20140904 | 20140904 | 0 | |
| 127736611 | 12773661 | 5 | 20140904 | 20140904 | 0 | |
| 127736611 | 12773661 | 6 | 20140904 | 20140904 | 0 | |
| 127736611 | 12773661 | 7 | 20140904 | 20140904 | 0 |